EIGER BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 28249U955. A total of 2 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $354 | -98.0% | 300 | -86.4% | 0.00% | – |
| Q1 2022 | $18,000 | 0.0% | 2,200 | -37.1% | 0.00% | – |
| Q4 2021 | $18,000 | -28.0% | 3,500 | -7.9% | 0.00% | – |
| Q3 2021 | $25,000 | -82.1% | 3,800 | -76.8% | 0.00% | – |
| Q2 2021 | $140,000 | +418.5% | 16,400 | +429.0% | 0.00% | – |
| Q1 2021 | $27,000 | +1250.0% | 3,100 | +1450.0% | 0.00% | – |
| Q3 2020 | $2,000 | -95.7% | 200 | -92.9% | 0.00% | -100.0% |
| Q1 2016 | $47,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 2,400 | $2 | 0.00% |